Xencor Inc (XNCR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.78B
Last updated: Nov 17, 2026 at 11:06 AM ET
Xencor Inc (XNCR) Stock Forecast
Analysts expect Xencor (XNCR) to earn -$2.27 per share in the fiscal year ending Dec 31, 2026, on revenue of $200.74M. Of 14 analysts, 12 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 1.93, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 86% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 21.4% |
| Buy | 9 | 64.3% |
| Hold | 2 | 14.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 14
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates fall 42.0%.
- Fiscal year ending Dec 31, 2026
- -$2.27
- EPS consensus, revenue $200.74M
- Fiscal year ending Dec 31, 2027
- -$3.76
- EPS consensus, revenue $116.41M
- Next report
- Feb 23, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.27 | -$2.77 to -$1.56 | 10 | $200.74M | $175.76M to $252.66M | 10 |
| Dec 31, 2027 | -$3.76 | -$5.39 to -$2.80 | 12 | $116.41M | $15.00M to $349.07M | 13 |
Quarterly Estimates
The EPS consensus falls from -$0.86 for the quarter ending Dec 31, 2026 to -$0.97 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.86 | -$1.27 to -$0.35 | 16 | $29.80M | $9.70M to $84.42M | 15 |
| Mar 31, 2027 | -$0.97 | -$1.31 to -$0.70 | 7 | $18.09M | $3.00M to $35.30M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$3.11.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.27 | -$3.07 | -$3.15 | -$3.15 | -$3.11 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.76 | -$3.54 | -$3.56 | -$3.55 | -$3.49 | N/A |
| Quarter ending Mar 31, 2027 | -$0.97 | -$0.93 | -$0.92 | -$0.92 | -$0.91 | N/A |
Frequently Asked Questions About XNCR
What is the XNCR stock forecast?
Consensus analyst estimates put Xencor's EPS at -$2.27 for the fiscal year ending Dec 31, 2026, on revenue of $200.74M. The consensus rating from 14 analysts is Buy.
How do analysts rate XNCR stock?
Of 14 analysts covering Xencor, 3 rate it Strong Buy, 9 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from XNCR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.27, with estimates from -$2.77 to -$1.56 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.76, with estimates from -$5.39 to -$2.80 from 12 analysts.
What revenue do analysts expect from Xencor next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $200.74M, with estimates from $175.76M to $252.66M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $116.41M, with estimates from $15.00M to $349.07M.
How many analysts cover XNCR?
14 analysts rate Xencor stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
XNCR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors